Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/28/2007EP1292381A4 Process and device for producing liquid dosage formulations
03/28/2007EP1292298B1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
03/28/2007EP1284134B1 External skin preparations for suppressing sebum secretion
03/28/2007EP1259239B1 USE OF 2-(4-ETHOXY-PHENYL)-3-(4-METHANESULFONYL-PHENYL)-PYRAZOLO[1,5-b]PYRIDAZINE FOR THE TREATMENT OF NON-ULCERATIVE DYSPEPSIA
03/28/2007EP1256581B1 Preventive or therapeutic agents for gastric or esophageal regurgitation
03/28/2007EP1255449B1 Nutritional formulation containing prebiotic substances
03/28/2007EP1233761B1 Osmotic dosage form comprising first and second coats
03/28/2007EP1228071B1 Pharmaceutically active isoindoline derivatives
03/28/2007EP1152760B1 Use of 4-amino pyridine for treatment of peripheral neuropathies
03/28/2007EP1096936B1 Treatment of dyskinesia through mu selective opioid antagonists
03/28/2007EP1082416B1 Poly(adp-ribose)polymerase gene
03/28/2007EP0991426B2 Method for transferring nucleic acid into the striated muscle
03/28/2007EP0957806B1 COMPOSITIONS TO CONTROL ORAL MICROBIAL OXIDATION-REDUCTION (E h) LEVELS
03/28/2007EP0927163B1 Preparation of 1-butyl-4-piperidinylmethylamine
03/28/2007EP0908182B2 Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos)
03/28/2007CN1938647A Composition and process for post-etch removal of photoresist and/or sacrificial anti-reflective material deposited on a substrate
03/28/2007CN1938429A Oligosaccharides, preparation method and use thereof, and pharmaceutical compositions containing same
03/28/2007CN1938326A Novel analgesic compounds, extracts containing same and methods of preparation
03/28/2007CN1938325A Synthetic membrane anchors
03/28/2007CN1938320A Compounds and methods for treating dyslipidemia
03/28/2007CN1938319A Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
03/28/2007CN1938318A Process for producing flavone C glycoside derivatives
03/28/2007CN1938317A Adiponectin increasing agent
03/28/2007CN1938314A Tetrahydroquinoline derivatives and a process for preparing the same
03/28/2007CN1938311A Macrocyclic compounds as inhibitors of viral replication
03/28/2007CN1938310A Imidazo 1,2-c pyrimidinylacetic acid derivatives
03/28/2007CN1938309A Crf receptor antagonists and methods relating thereto
03/28/2007CN1938308A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
03/28/2007CN1938307A 9-substituted 8-oxoadenine compound
03/28/2007CN1938306A Crystalline forms of 5, 11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one
03/28/2007CN1938305A 1,3,4-oxadiazol-2-ones as ppar delta modulators and their use thereof
03/28/2007CN1938304A Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
03/28/2007CN1938302A 激酶抑制剂 Kinase inhibitors
03/28/2007CN1938300A Oxadiazolone derivatives as PPAR delta agonists
03/28/2007CN1938299A Thioamide derivatives as progesterone receptor modulators
03/28/2007CN1938298A Methods for minimizing thioamide impurities
03/28/2007CN1938296A Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
03/28/2007CN1938294A Novel pyrrolidine-3,4-dicarboxamide derivatives
03/28/2007CN1938293A New compounds for the inhibition of angiogenesis and use of thereof
03/28/2007CN1938291A Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
03/28/2007CN1938289A Chromone complexes
03/28/2007CN1938287A Phenoxyacetic acid derivative and medicine containing the same
03/28/2007CN1938285A 4-anilinequinazolines with adenosine-kiase inhibitor properties
03/28/2007CN1938283A Pyridazinones as antagonists of alpha4 integrins
03/28/2007CN1938282A Imidazol derivatives as tyrosine kinase inhibitors
03/28/2007CN1938281A Ion channel modulators
03/28/2007CN1938276A Crystalline pyrazoles
03/28/2007CN1938275A Novel thio containing hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
03/28/2007CN1938274A Novel piperidines as chemokine modulators (CCR)
03/28/2007CN1938273A Tetrahydrocarbazoles and derivatives
03/28/2007CN1938272A Crystalline polymorph of bazedoxifene acetate
03/28/2007CN1938271A Crystalline polymorph of bazedoxifene acetate
03/28/2007CN1938269A Prolinyl derivatives for treating thrombosis
03/28/2007CN1938266A Sulfonamide compounds for the treatment of neurodegenerative disorders
03/28/2007CN1938265A Physiological cooling compositions containing highly purified ethyl ester of n-[[5-methyl-2-(1-methylethyl)cyclohexyl)carbonyl]glycine
03/28/2007CN1938264A Acid addition salts of 5-aminolevulinic acid or its derivatives
03/28/2007CN1938262A Quaternary ammonium compound, method for production thereof, and therapeutic agent for cerebrovascular disorder and heat disease
03/28/2007CN1938258A Ester derivatives of rhein and their therapeutic use
03/28/2007CN1938091A Method for the production of monodispersed pearl polymers containing acrylic
03/28/2007CN1938058A Solid pharmaceutical preparation for dialysis
03/28/2007CN1938048A 脂质体制剂 Liposomal formulations
03/28/2007CN1938036A Hemostatic agent for topical and internal use
03/28/2007CN1938035A Therapeutic use of cpg oligodeoxynucleotide for skin disease
03/28/2007CN1938034A ED-71 preparation
03/28/2007CN1938033A Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
03/28/2007CN1938032A Sustained-release oral molsidomine composition for treating atherosclerosis
03/28/2007CN1938031A Biaryl substituted pyrazinones as sodium channel blockers
03/28/2007CN1938030A Transdermal iontophoretic delivery of piperazinyl-2(3h)-benzoxazolone compounds
03/28/2007CN1938029A Chemokine inhibiting piperazine derivatives and their use to treat multiple myeloma
03/28/2007CN1938028A Anti-itching agent
03/28/2007CN1938027A 阿片样物质递送系统 Opioid delivery system
03/28/2007CN1938026A Controlled-release pharmaceutical composition and method for producing the same
03/28/2007CN1938025A Angiogenesis-affecting compounds and methods of use thereof
03/28/2007CN1938024A Combination of a heterocyclic compound and an antioxidant and use thereof for treating obesity
03/28/2007CN1938023A Ion channel modulators
03/28/2007CN1938022A Ion channel modulators
03/28/2007CN1938021A Ion channel modulators
03/28/2007CN1938020A Ion channel modulators
03/28/2007CN1938019A Protein kinase C inhibitors for the treatment of autoimmune diseases and of transplant rejection
03/28/2007CN1938018A Use of compounds that are able to increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level
03/28/2007CN1938017A Therapeutic combinations
03/28/2007CN1938016A Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
03/28/2007CN1938015A Compositions and methods of use of a-type procyanidins
03/28/2007CN1938014A Solid preparation containing dibenz[b,e]oxepine derivative
03/28/2007CN1938013A Methods and agents for inhibiting dynamin-dependent endocytosis
03/28/2007CN1938012A External preparation
03/28/2007CN1938011A Pharmaceutical product containing tranilast
03/28/2007CN1938010A Novel use of peptide compounds for treating pain in painful diabetic neuropathy
03/28/2007CN1938009A Compositions comprising vitamins and/or derivatives thereof stabilised with olea europea extract and/or ionene polymers
03/28/2007CN1936023A Diagnostic and monitoring methods for bone loss
03/28/2007CN1935849A Ultramicro chito polysaccharide product and its processing method
03/28/2007CN1935847A Pearl oyster homogenous polysaccharide and its use for preparing liver health product and medicine
03/28/2007CN1935846A Fusion protein for treating diabetes, and its preparing method and use
03/28/2007CN1935833A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
03/28/2007CN1935830A Upright datura flower steroid-lactone component, and its preparation and pharmaceutical use for antitumour
03/28/2007CN1935823A Novel compound neopuerarin A and its separating method
03/28/2007CN1935821A Antibacterial compound and its use
03/28/2007CN1935818A Adefovir dipivoxil novel crystallinestate, crystalline state composition, and itspreparing method and use
03/28/2007CN1935817A New acyclic nucleoside phosphate ester and its pharmaceutical use
03/28/2007CN1935812A Metal fullerol and its pharmaceutical use for inhibiting tumour growth
1 ... 3823 3824 3825 3826 3827 3828 3829 3830 3831 3832 3833 3834 3835 3836 3837 3838 3839 3840 3841 3842 3843 ... 7860